Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 8.86
+0.07 (0.80%)
May 8, 2026, 3:04 PM CST
SHE:300009 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 693.78 | 735.19 | 706.95 | 847.23 | 703.26 | 206.63 |
Depreciation & Amortization | 123.34 | 123.34 | 121.09 | 101.11 | 86.57 | 80.95 |
Other Amortization | 3.48 | 3.48 | 3.06 | 1.94 | 2.3 | 7.79 |
Loss (Gain) From Sale of Assets | -6.3 | -6.3 | -1.09 | -0.12 | 1.2 | -1.68 |
Asset Writedown & Restructuring Costs | 0.38 | 0.38 | 0.15 | 1.49 | 4.47 | 323.44 |
Loss (Gain) From Sale of Investments | -20.14 | -20.14 | -26.04 | 15.44 | -24.66 | -3.86 |
Provision & Write-off of Bad Debts | 8.33 | 8.33 | 7.19 | 20.12 | 5.37 | 4.62 |
Other Operating Activities | 20.3 | 33.28 | 15.86 | 13.3 | 11.02 | 3.7 |
Change in Accounts Receivable | -129.4 | -129.4 | -20.45 | -214.07 | -37.65 | -114.19 |
Change in Inventory | 14.14 | 14.14 | -69.93 | -30.55 | -36.62 | -27.47 |
Change in Accounts Payable | 97.03 | 97.03 | -69.59 | 131.79 | -75.73 | 123.87 |
Change in Other Net Operating Assets | 24.84 | 24.84 | 35.37 | 81.68 | 16.37 | 1.2 |
Operating Cash Flow | 808.82 | 863.22 | 685.37 | 952.97 | 698.98 | 592.17 |
Operating Cash Flow Growth | 11.43% | 25.95% | -28.08% | 36.34% | 18.04% | 27.41% |
Capital Expenditures | -129.79 | -126.89 | -117.22 | -195.34 | -474.34 | -131.23 |
Sale of Property, Plant & Equipment | 17.35 | 17.59 | 0.89 | 0.25 | 3.58 | 1.76 |
Cash Acquisitions | - | - | -1.2 | -8.13 | - | - |
Divestitures | - | - | - | 1.89 | 2.01 | - |
Investment in Securities | -508.82 | -366.92 | -91.42 | -447.98 | -101.07 | -103.07 |
Other Investing Activities | 27.62 | 23.22 | 38.7 | 32.04 | 25.94 | 61.44 |
Investing Cash Flow | -593.63 | -453 | -170.25 | -617.27 | -543.88 | -171.1 |
Short-Term Debt Issued | - | 7 | 5 | - | 3 | - |
Total Debt Issued | 7 | 7 | 5 | - | 3 | - |
Short-Term Debt Repaid | - | - | - | -3.03 | - | -14 |
Long-Term Debt Repaid | - | -15.93 | -10.37 | -7.24 | -7.56 | -3.63 |
Total Debt Repaid | -15.93 | -15.93 | -10.37 | -10.27 | -7.56 | -17.63 |
Net Debt Issued (Repaid) | -8.93 | -8.93 | -5.37 | -10.27 | -4.56 | -17.63 |
Issuance of Common Stock | 23.99 | 23.99 | - | 18.81 | 167.35 | - |
Repurchase of Common Stock | - | - | - | - | -40.06 | - |
Common Dividends Paid | -257.35 | -413.48 | -415.57 | -411.05 | -327.61 | -273.52 |
Other Financing Activities | -66.58 | -65.31 | -54.44 | 1.51 | 51.73 | 14.85 |
Financing Cash Flow | -308.87 | -463.73 | -475.38 | -400.99 | -153.15 | -276.3 |
Foreign Exchange Rate Adjustments | -4.59 | -6.89 | 0.08 | -0.11 | 0.06 | -0.01 |
Net Cash Flow | -98.27 | -60.4 | 39.82 | -65.4 | 2.01 | 144.76 |
Free Cash Flow | 679.03 | 736.33 | 568.15 | 757.64 | 224.64 | 460.94 |
Free Cash Flow Growth | 5.80% | 29.60% | -25.01% | 237.27% | -51.27% | 41.27% |
Free Cash Flow Margin | 26.53% | 27.82% | 22.40% | 26.44% | 9.64% | 21.25% |
Free Cash Flow Per Share | 0.41 | 0.44 | 0.34 | 0.45 | 0.14 | 0.29 |
Cash Income Tax Paid | 232.71 | 236.28 | 223.79 | 226.59 | 233.17 | 193.24 |
Levered Free Cash Flow | 436.08 | 519.22 | 360.54 | 591.82 | 194.46 | 450.42 |
Unlevered Free Cash Flow | 437 | 520.43 | 362.04 | 592.99 | 195.41 | 451.44 |
Change in Working Capital | -14.34 | -14.34 | -141.79 | -47.53 | -90.56 | -29.42 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.